JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB181219

Anti-CBLN1 抗体 [EPR13655]

Anti-CBLN1 antibody [EPR13655]

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Recombinant Monoclonal CBLN1 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 1 publication.

別名を表示する

Cerebellin-1, Precerebellin, CBLN1

1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CBLN1 antibody [EPR13655] (AB181219)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CBLN1 antibody [EPR13655] (AB181219)

Immunohistochemical analysis of paraffin embedded Human cerebellum tissue sections labeling CBLN1 using ab181219 at a 1/100 dilution. A ready to use HRP Polymer for Rabbit IgG was used as the secondary. Hematoxylin counterstain.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-CBLN1 antibody [EPR13655] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR13655

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製度
Tissue culture supernatant
バッファー組成
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

CBLN1 also known as C1q-like protein 4 is a protein of interest in the nervous system. It has a mass of approximately 33 kDa and is expressed largely in the cerebellum and other regions of the brain. CBLN1 plays a role in synapse formation and maintenance. It serves as a ligand to neurexins and other synaptic receptors facilitating synaptic integrity and plasticity essential for normal brain function.
Biological function summary

The function of CBLN1 is associated with the maintenance of neuronal communication. It is an integral part of a complex that includes the presynaptic neurexins and postsynaptic gridhub proteins contributing to synaptic organization. This protein ensures proper connectivity and signaling at the synaptic junctions which is critical for cognitive and motor activities.

Pathways

CBLN1 is involved in essential synaptic pathways critical for communication between neurons. It plays a significant part in the formation and maintenance of excitatory synapses working closely with neurexin proteins. CBLN1 is also associated with pathways involving cerebellar development where it interacts with cerebellar granule cells and their synaptic partners guiding proper synaptic targeting and function.

CBLN1 connections have implications in neurodegenerative diseases like cerebellar ataxias and schizophrenia. Disruption in the function or expression of CBLN1 can lead to synaptic dysfunction contributing to the pathology of these disorders. Among associated proteins dysfunctional interactions with GRID2 or neurexins have been observed in relation to these diseases linking the synaptic deficits observed with CBLN1 abnormalities.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Required for synapse integrity and synaptic plasticity. During cerebellar synapse formation, essential for the matching and maintenance of pre- and post-synaptic elements at parallel fiber-Purkinje cell synapses, the establishment of the proper pattern of climbing fiber-Purkinje cell innervation, and induction of long-term depression at parallel fiber-Purkinje cell synapses. Plays a role as a synaptic organizer that acts bidirectionally on both pre- and post-synaptic components. On the one hand induces accumulation of synaptic vesicles in the pre-synaptic part by binding with NRXN1 and in other hand induces clustering of GRID2 and its associated proteins at the post-synaptic site through association of GRID2. NRXN1-CBLN1-GRID2 complex directly induces parallel fiber protrusions that encapsulate spines of Purkinje cells leading to accumulation of GRID2 and synaptic vesicles. Required for CBLN3 export from the endoplasmic reticulum and secretion (By similarity). NRXN1-CBLN1-GRID2 complex mediates the D-Serine-dependent long term depression signals and AMPA receptor endocytosis (PubMed : 27418511). Essential for long-term maintenance but not establishment of excitatory synapses (By similarity). Inhibits the formation and function of inhibitory GABAergic synapses in cerebellar Purkinje cells (By similarity).. The cerebellin peptide exerts neuromodulatory functions. Directly stimulates norepinephrine release via the adenylate cyclase/PKA-dependent signaling pathway; and indirectly enhances adrenocortical secretion in vivo, through a paracrine mechanism involving medullary catecholamine release (By similarity).
See full target information CBLN1

文献 (1)

Recent publications for all applications. Explore the full list and refine your search

Oncotarget 9:24291-24303 PubMed29849941

2018

A novel liver metastasis-correlated protein of pancreatic neuroendocrine neoplasm (PanNEN) discovered by proteomic analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Mitsuhiro Shimura,Masamichi Mizuma,Tatsuyuki Takadate,Yasutake Katoh,Takashi Suzuki,Masahiro Iseki,Tatsuo Hata,Shuichi Aoki,Yukie Suzuki,Naoaki Sakata,Hideo Ohtsuka,Hiroki Hayashi,Takanori Morikawa,Kei Nakagawa,Fuyuhiko Motoi,Takeshi Naitoh,Kazuhiko Igarashi,Hironobu Sasano,Michiaki Unno
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com